Doximity Inc (DOCS)

Currency in USD
28.34
+0.84(+3.05%)
Real-time Data·
DOCS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
26.9828.34
52 wk Range
23.6680.25
Key Statistics
Prev. Close
27.5
Open
27.76
Day's Range
26.98-28.34
52 wk Range
23.66-80.25
Volume
863.98K
Average Volume (3m)
3.3M
1-Year Change
-66.0933%
Book Value / Share
5.2
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DOCS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
41.38
Upside
+46.02%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Doximity Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Doximity Inc Company Profile

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Employees
830

Doximity Inc SWOT Analysis


Digital Health Giant
Doximity dominates the healthcare professional network space, connecting over 2 million medical professionals and serving top pharmaceutical manufacturers and health systems.
Financial Resilience
Explore Doximity's robust financial performance, with a 90.2% gross profit margin and 19.98% revenue growth, showcasing its operational excellence in the digital health sector.
Market Valuation
Analysts offer diverse price targets for Doximity, ranging from $55 to $80, reflecting varied perspectives on the company's growth potential and market position.
AI-Driven Future
Delve into Doximity's strategic AI investments, including an ambient scribe tool, poised to revolutionize healthcare professional engagement and drive long-term revenue growth.
Read full SWOT analysis

Doximity Inc Earnings Call Summary for Q3/2026

  • Doximity reported Q3 2026 EPS of $0.46 (beating $0.45 forecast) and revenue of $185.1M (10% YoY growth), yet stock fell 5.48% in after-hours trading to $34.68
  • Company maintained 60% adjusted EBITDA margin ($111.4M) with 112% net revenue retention rate and repurchased $196.8M in shares during the quarter
  • Q4 2026 revenue guidance set at $143-144M (4% growth), with full fiscal year projection of $642.5-643.5M (13% growth)
  • CEO Jeff Tangney emphasized physician oversight in AI development as the company plans to commercialize its AI products later this year
  • Management noted strong interest in AI products from healthcare systems while acknowledging risks from policy uncertainty and potential market saturation
Last Updated: 06/02/2026, 00:22
Read Full Transcript

Compare DOCS to Peers and Sector

Metrics to compare
DOCS
Peers
Sector
Relationship
P/E Ratio
21.4x11.4x−0.5x
PEG Ratio
1.120.040.00
Price/Book
5.2x1.6x2.6x
Price / LTM Sales
8.0x1.6x3.3x
Upside (Analyst Target)
45.5%71.4%45.0%
Fair Value Upside
Unlock29.9%5.1%Unlock

Analyst Ratings

16 Buy
5 Hold
0 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 41.38
(+46.02% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Mizuho
Hold34.00+21.00%45.00MaintainFeb 10, 2026
Baird
Buy40.00+42.35%80.00MaintainFeb 09, 2026
Goldman Sachs
Hold34.00+21.00%46.00MaintainFeb 09, 2026
Canaccord Genuity
Buy34.00+21.00%48.00UpgradeFeb 09, 2026
Canaccord Genuity
Buy34.00+21.00%48.00UpgradeFeb 09, 2026

Earnings

Latest Release
Feb 05, 2026
EPS / Forecast
0.46 / 0.45
Revenue / Forecast
185.10M / 181.63M
EPS Revisions
Last 90 days

DOCS Income Statement

People Also Watch

565.93
SNDK
-2.99%
304.14
TER
-1.89%
62.40
FISV
+3.76%
107.91
NOW
+3.89%
144.37
PLTR
+1.02%

FAQ

What Is the Doximity (DOCS) Premarket Price Today?

The Doximity (DOCS) premarket price is 27.45. Premarket price change units: -0.05. Premarket percentage change: -0.18%. Premarket volume: 9,240.00. Current date: 10 Feb 2026. Previous close: 27.50

What Stock Exchange Does Doximity Trade On?

Doximity is listed and trades on the New York Stock Exchange. TEST USD

What Is the Stock Symbol for Doximity?

The stock symbol for Doximity is "DOCS."

What Is the Doximity Market Cap?

As of today, Doximity market cap is 5.18B.

What Is Doximity's Earnings Per Share (TTM)?

The Doximity EPS (TTM) is 1.19.

When Is the Next Doximity Earnings Date?

Doximity will release its next earnings report on 18 May 2026.

From a Technical Analysis Perspective, Is DOCS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Doximity Stock Split?

Doximity has split 0 times.

How Many Employees Does Doximity Have?

Doximity has 830 employees.

What is the current trading status of Doximity (DOCS)?

As of 10 Feb 2026, Doximity (DOCS) is trading at a price of 28.34, with a previous close of 27.50. The stock has fluctuated within a day range of 26.98 to 28.34, while its 52-week range spans from 23.66 to 80.25.

What Is Doximity (DOCS) Price Target According to Analysts?

The average 12-month price target for Doximity is USD41.38, with a high estimate of USD63 and a low estimate of USD25. 16 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +46.02% Upside potential.

What Is the DOCS Premarket Price?

DOCS's last pre-market stock price is 27.45. The pre-market share volume is 9,240.00, and the stock has decreased by -0.05, or -0.18%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.